Therma Bright Inc. (JNX0)
Market Open
7 Aug, 20:00
XFRA 
€
0. 02
-0.01
-36%
€
- Market Cap
- P/E Ratio
- Div Yield
3,750 Volume
0 Eps
€ 0.03
Previous Close Want to track JNX0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
JNX0 trading today lower at €0.02, a decrease of -36% from yesterday's close, completing a monthly increase of 0% or €0. Over the past 12 months, JNX0 stock lost -15.7895%.
JNX0 is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Therma Bright Inc. has completed 1 stock splits, with the recent split occurring on Jul 08, 2025.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).
JNX0 Chart
Therma Bright Inc. (JNX0) FAQ
What is the stock price today?
The current price is €0.02.
On which exchange is it traded?
Therma Bright Inc. is listed on XFRA.
What is its stock symbol?
The ticker symbol is JNX0.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Therma Bright Inc. ever had a stock split?
Therma Bright Inc. had 1 splits and the recent split was on Jul 08, 2025.
Therma Bright Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Roberto Fia CEO | XFRA Exchange | CA8834262070 ISIN |
| CA Country | 5 Employees | - Last Dividend | 8 Jul 2025 Last Split | - IPO Date |
Overview
Therma Bright Inc. is a forward-thinking company dedicated to innovation in the healthcare sector, specializing in the development and sale of a variety of medical devices and rapid testing products. Initially known as The Jenex Corporation, the company underwent a name change to Therma Bright Inc. in February 2018 to better reflect its expanded focus and vision. Founded in 2001 and headquartered in Toronto, Canada, Therma Bright Inc. caters both to consumers and medical professionals, striving to improve health outcomes with its technology-driven solutions. The areas of focus include rapid COVID-19 testing, pain management, circulation improvement, and advancements within the cosmeceutical industry.
Products and Services
- AcuVid - This is an antigen and antibody rapid screening test designed for the detection of COVID-19. Its quick and efficient testing process aids in the effective management and containment of COVID-19 outbreaks.
- InterceptCS - A revolutionary cold sore prevention system, InterceptCS utilizes controlled topical heat to prevent cold sore outbreaks without the risk of burning the skin, providing a safe and effective alternative to traditional treatments.
- Benepod - This device employs hot and cold contrast therapy to offer pain relief. Benepod is designed for individuals seeking an alternative to pain relieving medications, offering an innovative solution for managing discomfort.
- Venowave - Venowave is a medical compression pump that addresses and alleviates symptoms associated with poor circulation. This device is particularly beneficial for people suffering from conditions that impair blood flow, enhancing their quality of life.
- TherOZap - A thermal therapy insect device, TherOZap is engineered to reduce the inflammatory response and relieve symptoms associated with insect bites and stings, such as pain, itching, and inflammation, offering a natural remedy for outdoor enthusiasts and individuals in insect-prone areas.
Contact Information
Address: 345 Danforth Avenue
Phone: 844 274 6837
Website: https://www.thermabright.com
